Cytokine therapy-mediated neuroprotection in a Friedreich's ataxia mouse model
about
Pharmacological therapeutics in Friedreich ataxia: the present state.Mesenchymal Stem Cell-Derived Factors Restore Function to Human Frataxin-Deficient Cells.Bone marrow transplantation stimulates neural repair in Friedreich's ataxia mice.Advances in Biomarker-Guided Therapy for Pediatric- and Adult-Onset Neuroinflammatory Disorders: Targeting Chemokines/Cytokines.
P2860
Cytokine therapy-mediated neuroprotection in a Friedreich's ataxia mouse model
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 23 December 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Cytokine therapy-mediated neuroprotection in a Friedreich's ataxia mouse model
@en
Cytokine therapy-mediated neuroprotection in a Friedreich's ataxia mouse model.
@nl
type
label
Cytokine therapy-mediated neuroprotection in a Friedreich's ataxia mouse model
@en
Cytokine therapy-mediated neuroprotection in a Friedreich's ataxia mouse model.
@nl
prefLabel
Cytokine therapy-mediated neuroprotection in a Friedreich's ataxia mouse model
@en
Cytokine therapy-mediated neuroprotection in a Friedreich's ataxia mouse model.
@nl
P2093
P2860
P50
P356
P1433
P1476
Cytokine therapy-mediated neuroprotection in a Friedreich's ataxia mouse model
@en
P2093
Alastair Wilkins
Amelia J Cook
Bronwen R Burton
Harry R Haynes
Juliana Redondo
Kelly Hares
P2860
P304
P356
10.1002/ANA.24846
P577
2017-02-01T00:00:00Z